Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
fuganlin (1 trial)
polidocanol (asclera) (1 trial)
xiaoer jiebiao (1 trial)
Communicable Diseases (Phase 4)
Hemorrhoids (Phase 4)
Infections (Phase 4)
Respiratory Tract Infections (Phase 4)
Trials (2 total)
Trial APIs (3 total)